EO-NORMAL-AF Study
- Conditions
- Heart FailureD006333
- Registration Number
- JPRN-jRCTs052210060
- Lead Sponsor
- ishida Taku
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
1 Hospitalized patients due to acute heart failure or acute exacerbation of chronic heart failure
2 LVEF 40% or more measured by echocardiography recorded within 2 weeks before getting written consent
3 Ages 20 and over
1 Patients with persistent atrial fibrillation or bradyarrhythmia ,which has indication for pacemaker implantation, detected by 12 leads electrocardiogram during hospitalization
2 Patients with tachyarrhythmia ,which has indication for cardiac implantable electronic device or catheter ablation, detected during hospitalization
3 Patients with cardiac implantable electronic device
4 Expected prognosis less than 1 year
5 Inappropriate patients judged by attending doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The presence / absence# of new onset of atrial fibrillation(recurrence of atrial fibrillation in the case of paroxysmal atrial fibrillation)detected at 12 months after ILR implantation#<br>*Definition of atrial fibrillation detected with ILR:6 minutes and more persistent atrial fibrillation
- Secondary Outcome Measures
Name Time Method